News Image

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

Provided By PR Newswire

Last update: Sep 26, 2025

MINNEAPOLIS, Sept. 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, today announced new advancements in its spatial biology portfolio for the RNAscopeā„¢ ISH technology and the Lunaphore COMETā„¢. These solutions help researchers and pathologists bridge the gap between translational research and clinical applications by enabling the detection of RNA and protein biomarkers on the same tissue section.

Read more at prnewswire.com

BIO-TECHNE CORP

NASDAQ:TECH (11/20/2025, 8:00:01 PM)

After market: 58.83 +0.1 (+0.17%)

58.73

+0.92 (+1.59%)



Find more stocks in the Stock Screener

TECH Latest News and Analysis

Follow ChartMill for more